Pacer Advisors
MDGL icon

Pacer Advisors’s Madrigal Pharmaceuticals MDGL Stock Holding History

Pacer Advisors’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-207
Closed -$58K – 2636
2024
Q2 		$58K Buy
207
+37
+22% +$8.81K ﹤0.01% 3043
2024
Q1 		$45.4K Buy
+170
New +$40.1K ﹤0.01% 3207
2021
Q2 		– Sell
-656
Closed -$77K – 1491
2021
Q1 		$77K Sell
656
-330
-33% -$38.5K ﹤0.01% 1333
2020
Q4 		$110K Buy
986
+150
+18% +$18.3K ﹤0.01% 1354
2020
Q3 		$99K Buy
+836
New +$90.8K ﹤0.01% 1250
2018
Q4 		– Sell
-1,078
Closed -$231K – 842
2018
Q3 		$231K Buy
+1,078
New +$271K 0.01% 1002

Other funds holding MDGL

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return